🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 2 double-blind, placebo-controlled study of AL001 in participants w...
Status
Terminated
Location
University of South Florida
Start Date
2021-09-02
Trial ID
NCT05053035
Continuation study to provide continued access to latozinemab for participa...
Status
Terminated
Location
Dignity Health - Arizona
Start Date
2023-12-08
Trial ID
NCT06111014
Treatments Being Tested
This study is designed to evaluate long-term safety and efficacy of AL-001 ...
Status
Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Hospital
Start Date
2024-12-09
Trial ID
NCT06718816
This Phase II study is designed to evaluate the efficacy and safety of AL-0...
Status
Not Yet Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Hospital
Start Date
2025-02-18
Trial ID
NCT06839339
Treatments Being Tested
This Phase I/IIa study is designed to evaluate the safety, tolerability, pr...
Status
Active Not Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Hospital
Start Date
2023-09-11
Trial ID
NCT06707753
Treatments Being Tested
This is a Phase 1/2a, multi-center, placebo-controlled, double-blinded, ran...
Status
Completed
Location
CenExel iResearch, LLC
Start Date
2022-05-04
Trial ID
NCT05363293
The goal of this clinical trial is to assess the safety and effects of a cr...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2026-05-11
Trial ID
NCT07540338
Treatments Being Tested
A phase 3 double blind, placebo controlled study evaluating the efficacy an...
Status
Terminated
Location
Dignity Health
Start Date
2020-07-23
Trial ID
NCT04374136
Treatments Being Tested
The goal of this clinical trial is to assess the safety and effects of a cr...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2025-05-09
Trial ID
NCT06921590
Treatments Being Tested
A first in human phase 1 study in healthy volunteers and participants with ...
Status
Completed
Location
University of Alabama
Start Date
2018-09-14
Trial ID
NCT03636204